Israel to buy Moderna's booster shot against COVID-19 variants

Moderna Inc (MRNA.O) said on Tuesday it had secured a new COVID-19 vaccine supply agreement with Israel for 2022, under which the country has the option to buy doses of one of the company's variant-specific vaccine candidates. The announcement follows two earlier agreements between Israel and Moderna to supply a total of 10 million doses of the COVID-19 vaccine. Moderna's COVID-19 booster vaccine is in early-stage trials. The company in April said it should be able to provide a booster shot for protection against variants of the novel coronavirus by the end of this year.